Cas 1147834-79-4,estradiol-17β-O-4-oxobutanoyl-Arg(Nω-NO2)-Gly-Asp(OBn)-Ser(Bn)-Arg(Nω-NO2)-Gly-Asp(OBn)-Ser(Bn)-OBn

1147834-79-4

Post Buying Request

Basic information

Product Name: estradiol-17β-O-4-oxobutanoyl-Arg(Nω-NO2)-Gly-Asp(OBn)-Ser(Bn)-Arg(Nω-NO2)-Gly-Asp(OBn)-Ser(Bn)-OBn
Synonyms: estradiol-17β-O-4-oxobutanoyl-Arg(Nω-NO2)-Gly-Asp(OBn)-Ser(Bn)-Arg(Nω-NO2)-Gly-Asp(OBn)-Ser(Bn)-OBn
CAS NO:1147834-79-4
Molecular Formula:
Molecular Weight: 1743.89
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: estradiol-17β-O-4-oxobutanoyl-Arg(Nω-NO2)-Gly-Asp(OBn)-Ser(Bn)-Arg(Nω-NO2)-Gly-Asp(OBn)-Ser(Bn)-OBn(CAS DataBase Reference)
NIST Chemistry Reference: estradiol-17β-O-4-oxobutanoyl-Arg(Nω-NO2)-Gly-Asp(OBn)-Ser(Bn)-Arg(Nω-NO2)-Gly-Asp(OBn)-Ser(Bn)-OBn(1147834-79-4)
EPA Substance Registry System: estradiol-17β-O-4-oxobutanoyl-Arg(Nω-NO2)-Gly-Asp(OBn)-Ser(Bn)-Arg(Nω-NO2)-Gly-Asp(OBn)-Ser(Bn)-OBn(1147834-79-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1147834-79-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1147834-79-4 Suppliers

Recommended suppliers

1147834-79-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1147834-79-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,4,7,8,3 and 4 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1147834-79:
(9*1)+(8*1)+(7*4)+(6*7)+(5*8)+(4*3)+(3*4)+(2*7)+(1*9)=174
174 % 10 = 4
So 1147834-79-4 is a valid CAS Registry Number.

1147834-79-4Upstream product

1147834-79-4Downstream Products

1147834-79-4Relevant academic research and scientific papers

Synthesis, evaluation and 3D QSAR analysis of novel estradiol-RGD octapeptide conjugates with oral anti-osteoporosis activity

Liu, Jiangyuan,Zhang, Xiaoyi,Zhao, Ming,Peng, Shiqi

experimental part, p. 1689 - 1704 (2009/05/26)

To enhance the potency, reduce the side effects and improve oral property of estradiol in estrogen replacement therapy (ERT), 6 novel estradiol-RGD octapeptide conjugates have been prepared. In an ovariectomized mouse osteoporotic model, at an oral dosage

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1147834-79-4